FDA issues safety alert on breast implant-associated cancers
The Food and Drug Administration yesterday alerted health care providers and the public to reports of squamous cell carcinoma in scar tissue around breast implants, as well as lymphomas different than those previously associated with breast implants. The agency recommends that health care providers continue to report cancers around breast implants to help it identify and better understand this emerging issue.
Related News Articles
Headline
Life expectancy in the U.S. reached an all-time high of 79 years in 2024, according to a report by the Centers for Disease Control and Prevention. The average…
Headline
Ji Im, system senior director of community and population health at CommonSpirit Health, explores why seamless navigation, community partnerships and…
Headline
(Updated Jan. 23) A measles outbreak in South Carolina has reached 700 cases, the state’s Department of Public Health reported. The outbreak, initially…
Headline
Jesse Tamplen, vice president of care coordination at John Muir Health in San Francisco, and Jamie Elmasu, director of community health improvement at John…
Headline
A study released Jan. 12 by the Journal of the American College of Cardiology analyzed the current state of heart health in the U.S., highlighting the…
Blog
As hospitals and health systems look for sustainable and scalable solutions to help address rising behavioral health needs across the country, digital tools…